Expertise in
18
conditions

Knut Brockow

Biedersteiner Str. 29, 
Munich, BY, DE 
Expertise in
18
conditions
Biedersteiner Str. 29, 
Munich, BY, DE 

Overview

Knut Brockow practices practicing medicine in Munich, Germany.

Mr. Brockow is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Anaphylaxis, Mast Cell Activation Syndrome (MCAS), Grass Allergy, and Systemic Mastocytosis.

He is actively involved in clinical research, co-authoring 310 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Biedersteiner Str. 29, Munich, BY 80802, Germany
Other Locations
Ismaninger Str. 22, Munich, BY 81675, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2025
Intervention Type: Drug
Study Drug: Avapritinib
Study Phase: Phase 2

310 Total Publications

Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.
Journal: Experimental hematology & oncology
Published: June 21, 2026

Frequently Asked Questions about Knut Brockow

Is Knut Brockow a top-rated expert for Anaphylaxis?

MediFind is an objective health platform that identifies experts based on real-world data. Knut Brockow is classified as an Elite expert for Anaphylaxis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Knut Brockow participate in research or clinical trials?

Yes. Knut Brockow has published 310 articles and abstracts on conditions like Anaphylaxis. You can view a list of Knut Brockow's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Brockow's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile